Friday , December 3 2021

The new Japanese medicine that cures the flu for 24 hours – Noticias Ya


(NEWS YA) .-Japanese doctors already work on a drug that can kill the flu virus one day, announced Friday Health Ministry in Japan.

According to its manufacturer, Shionogi & Co., Ltd., the tablets promise to kill the flu in 24 hours and they were approved this friday.

One attempt showed it Xofluza was faster at killing the influenza virus than anyone else available treatment, including Roche AG's Tamiflu, one of the best in the market.

The Food and Drug Administration (FDA) gave him approval of medicine Xofluza to the manufacturer, last October.

Wall Street Journal suggests that, Rapid approval would mean that Shionogi & Co. may start selling Xofluza.

Just a handful of new drugs, including Tamiflu, they exist to treat people when they are infected.

Existing drugs allow the virus to absorb the cells and instead work to prevent the virus from flying and infecting other cells. Xofluza It seems to prevent the influenza virus from taking over the cells, "said Shionogi CEO Isao Teshirogi.

Xofluza, which works differently from existing flu medicines, It requires a single dose.

The trial of patients with flu from Japan and the United States, found it The average time taken by Xofluza to eliminate the virus was 24 hours. Tamiflu took three times longer to achieve the same result in the test.

but The pill may not be available in Japan before May because the national insurer has not yet decided a price, said a company's spokesman.

Shionogi, based in Osaka, plans to request approval from the United States. UU. this year Roche in Switzerland has already acquired the license to sell Xofluza abroad, even in the United States. UU.

Moreover, Johnson & Johnson and AstraZeneca PLC are some of the other companies that test new compounds to treat influenza A, the most common flu strain.

However, it may be several years before their discoveries are commercially available.

Shionogi says his medicine is also working against Tribes of influenza B and experts believe that it may be a breakthrough in how the disease is treated.

Source link